Top compounds associated with response to LGALS9


Feature Type Standardized
Nominal ANOVA
mRNA Ki8751 CTRPv2 pan-cancer AAC 0.16 7e-05
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 7e-05
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 8e-05
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 8e-05
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 0.0001
mRNA clofarabine CTRPv2 pan-cancer AAC 0.12 0.0001
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 0.0001
mRNA GSK1120212 CTRPv2 pan-cancer AAC 0.2 0.0001
mRNA AZD0530 CTRPv2 pan-cancer AAC 0.15 0.0002
mRNA KIN001-102 GDSC1000 pan-cancer AAC 0.12 0.0002
Download CSV